Latest filing published 07 Aug 2026 for Braveheart Bio, Inc..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Forbion Growth Opportunities Fund III Cooperatief U.A.: trading record in brief
All filings by Forbion Growth Opportunities Fund III Cooperatief U.A. on record concern Braveheart Bio, Inc. We count 4 filings, every one of them for a trade on 7 August 2026.
Purchases make up the whole of the open-market record (2 purchases, €56.2M). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The newest entry dates from 7 August 2026: a transaction, in Braveheart Bio, Inc. The last purchase on record was published on 7 August 2026, which is 94 days ago. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Forbion Growth Opportunities Fund III Cooperatief U.A.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 9,132,420 shares0Common StockSEC:0001193125-26-340528:0
- 7,990,867 shares0Common StockSEC:0001193125-26-340528:1
- 1,920,000 shares@ US$18.00Common StockSEC:0001193125-26-340528:2Canonical exit: 5 Nov 2026 (T+90)
- 1,680,000 shares@ US$18.00Common StockSEC:0001193125-26-340528:3Canonical exit: 5 Nov 2026 (T+90)
4 of 4 declarations